Rachel Ruth Wright

US Patent:

20040142331, Jul 22, 2004

Filed:

Aug 11, 2003

Appl. No.:

10/363829

Inventors:

Stuart Jackson - Santa Cruz CA, US
Stephen Lincoln - Potomac MD, US
Christina Altus - Campbell CA, US
Gerard Dufour - Castro Valley CA, US
Michael Chalup - Livingston TX, US
Jennier Jackson - Santa Cruz CA, US
Anissa Jones - San Jose CA, US
Jimmy Yu - Fremont CA, US
Rachel Wright - Mountain View CA, US
Darryl Gietzen - San Jose CA, US
Tommy Liu - Daly City CA, US
Pierre Yap - Lafayette CA, US
Christopher Dahl - Longview TX, US
Monika Momiyama - Hayward CA, US
Diana Bradley - Soquel CA, US
Sameer Rohatgi - San Francisco CA, US
Bernard Harris - Sunnyvale CA, US
Ann Roseberry Lincoln - Potomac MD, US
Edward Gerstin - San Jose CA, US
Careyna Peralta - Santa Clara CA, US
Marie David - Daly City CA, US
Scott Panzer - Sunnyvale CA, US
Vincent Flores - Union City CA, US
Abel Daffo - San Jose CA, US
Rakesh Marwaha - Burnaby, CA
Alice Chen - San Jose CA, US
Simon Chang - Sunnyvale CA, US
Alan Au - Mountain View CA, US
Rebekah Inman - Mountain View CA, US

International Classification:

C12Q001/68
C07H021/04
C07K014/705

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The present invention provides purified disease detection and treatment molecule polynucleotides (mddt). Also encompassed are the polypeptides (MDDT) encoded by mddt. The invention also provides for the use of mddt, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing mddt for the expression of MDDT. The invention additionally provides for the use of isolated and purified MDDT to induce antibodies and to screen libraries of compounds and the use of anti-MDDT antibodies in diagnostic assays. Also provided are microarrays containing mddt and methods of use.